Some academics, for instance, think that CROs like Quintiles should stay away from analyzing data.
FORBES: The Next Billionaire: A Statistician Who Changed Medicine
Many of the project leaders in offshore CROs are Big Pharma trained medicinal chemists.
CROs can hire researchers, nurses and computer staff at less than a third of western wages.
Color photography was invented at the same time by Charles Cros and by Louis Ducos du Hauron, in France.
The ecosystem is changing and CROs are both driving and benefiting from it.
Clinical trial management expertise has also flowed out of Pharma and into CROs.
CROs that work for them have preferred to test therapies closer to home.
Over the past decade, Big Pharma organizations have supported, willingly or not, a huge knowledge and talent transfer to CROs .
One reason why I think CROs are likely to be change-makers for the drug industry is their culture: they are by nature cost-conscious businesses .
Despite the influx of daytrippers, the island of Porquerolles is wholly unspoilt: most of its white sandy beaches and pine woods are protected by the Parc National de Port-Cros.
He expects more strategic deals, although his poll found the average number of CROs used will drop by 6.5 percent this year to 5 for each biopharma.
FORBES: Whither Contract Research Organizations: A Glass Half Full?
An obvious ecosystem trend is that large pharma disgorges itself of more research sites and infrastructure, some of which will be shut down, others absorbed into existing CROs or spun-out into new ones.
How might this play out for some CROs?
FORBES: Whither Contract Research Organizations: A Glass Half Full?
And to help enhance their access the startup market, and leverage the efficiency of relationships, I also believe CROs will increasingly rely on ever tighter connections with biotech venture capital firms to access portfolios of assets requiring outsourced functions.
Its intriguing to entertain the idea that putting CROs closer to the center of the ecosystem could be a key ingredient in allowing the drug business to maintain its focus on innovating but doing it while reducing system costs.
应用推荐